1 March 2010 In vitro testing of a protease-sensitive contrast agent for optoacoustic imaging
Author Affiliations +
Abstract
We have designed a protease-sensitive imaging probe for optoacoustic imaging whose absorption spectrum changes upon cleavage by a protease of interest. The probe comprises an active site, a derivative of chlorophyll or natural photosynthetic bacteriochlorophyll that absorbs in the near infrared, conjugated to a peptide backbone specific to the protease being imaged. The uncleaved molecules tend to aggregate in dimers and trimers, causing a change in the absorption spectrum relative to that of the monomer. Upon cleavage, the probe molecules deaggregate, giving rise to a spectrum characteristic of monomers. We show using photospectrometry that the two forms of the probe have markedly different absorption spectra, which could allow for in vivo optoacoustic identification using a multiwavelength imaging strategy. Optoacoustic measurements using a narrow-band dye laser find spectral peaks in the two forms of the probe at the expected location. The optoacoustic signal from the uncleaved probe is found to be considerably weaker than that of the cleaved probe, perhaps due to poor optical-acoustic coupling in the aggregated molecules. However, ultimately, it is detection of the cleaved probe that is of the greatest import, since it reports on the protease activity of interest.
© (2010) Society of Photo-Optical Instrumentation Engineers (SPIE)
Anthony Green, James R. Norris, Jing Wang, Zhixing Xie, Hao F. Zhang, Patrick J. La Rivière, "In vitro testing of a protease-sensitive contrast agent for optoacoustic imaging," Journal of Biomedical Optics 15(2), 021315 (1 March 2010). https://doi.org/10.1117/1.3365935 . Submission:
JOURNAL ARTICLE
8 PAGES


SHARE
Back to Top